MAPC Transplantation Confers a more Durable Benefit than AC133 Cell Transplantation in Severe Hind Limb Ischemia

MAPC Transplantation Confers a more Durable Benefit than AC133 Cell Transplantation in Severe Hind Limb Ischemia

There is a need for comparative studies to determine which cell types are better candidates to remedy ischemia. Here, we compared human AC133 + cells and multipotent adult progenitor cells (hMAPC) in a mouse model reminiscent of critical limb ischemia. hMAPC or hAC133 + cell transplantation induced...

Full description

Bibliographic Details
Main Authors: Xabier L. Aranguren, Beatriz Pelacho, Ivan Peñuelas, Gloria Abizanda, Maialen Uriz, Margarita Ecay, María Collantaes, Miriam Araña, Manu Beerens, Giulia Coppiello, Inés Prieto, Maitane Perez-Ilzarbe, Enrique J. Andreu, Aernout Luttun, Felipe Prósper
Format: Article
Language:English
Published: SAGE Publishing 2011-03-01
Series:Cell Transplantation
Online Access:https://doi.org/10.3727/096368910X516592

Internet

https://doi.org/10.3727/096368910X516592

Similar Items